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Pneumonia is an important cause of illness and death in 
England. To describe trends in pneumonia hospitalizations, 
we extracted information on all episodes of pneumonia that 
occurred from April 1997 through March 2005 recorded in 
the Hospital Episode Statistics (HES) database by search-
ing for International Classiﬁ  cation of Diseases 10th revision 
codes J12–J18 in any diagnostic ﬁ  eld. The age-standard-
ized incidence of hospitalization with a primary diagnosis of 
pneumonia increased by 34% from 1.48 to 1.98 per 1,000 
population between 1997–98 and 2004–05. The increase 
was more marked in older adults, in whom the mortality rate 
was also highest. The proportion of patients with recorded 
coexisting conditions (deﬁ  ned by using the Charlson Comor-
bidity Index score) increased over the study period. The rise 
in pneumonia hospital admissions was not fully explained 
by demographic change or increasing coexisting conditions. 
It may be attributable to other population factors, changes in 
HES coding, changes to health service organization, other 
biologic phenomenon, or a combination of these effects.
C
ommunity-acquired pneumonia is an important cause 
of illness and death in the United Kingdom, particu-
larly for elderly adults. In recent years, increases in hospital 
admissions for pneumonia have been noted in the United 
States (1,2), Denmark (3), and the Netherlands (4). It has 
been suggested that this rise is due to an aging population 
and an increased prevalence of coexisting conditions (such 
as diabetes and chronic obstructive pulmonary disease); 
however, these factors seem to only partially explain the 
observed increase in pneumonia hospitalizations (2). Fur-
thermore, these increases have occurred despite widespread 
inﬂ   uenza and pneumococcal vaccination programs that 
target the elderly. Streptococcus pneumoniae is a leading 
cause of community-acquired pneumonia (5,6), but the 23-
valent pneumococcal polysaccharide vaccine currently rec-
ommended for the elderly in the United Kingdom has little 
efﬁ  cacy against nonbacteremic pneumonia (7). A 7-valent 
pneumococcal conjugate vaccine (PCV7) was introduced 
into the United Kingdom infant immunization schedule in 
September 2006 (8). Experience with PCV7 in the United 
States suggests that, by reducing carriage and thus the op-
portunity for transmission of vaccine types, vaccination can 
lead to a reduction in invasive pneumococcal disease (9) 
and pneumonia (10) in unvaccinated cohorts. We report on 
the epidemiology of pneumonia before PCV7 vaccination 
was introduced by examining trends in hospital admissions 
for pneumonia in England during an 8-year period (April 
1997 through March 2005).
Materials and Methods
The Hospital Episode Statistics (HES) from the Na-
tional Health Service (NHS) Information Centre for Health 
and Social Care contains details of all admissions to NHS 
hospitals in England (www.hesonline.org.uk). The data-
base holds information on patient characteristics and clini-
cal diagnoses and procedures, in addition to geographic and 
administrative data. Diagnoses in HES are recorded in up 
to 14 diagnostic ﬁ  elds by using the International Classiﬁ  ca-
tion of Diseases, 10th revision (ICD-10), coding system.
Each record in the HES database relates to 1 “ﬁ  nished 
consultant episode.” This is the period a person spends un-
der the care of 1 NHS consultant during a single hospital 
admission; multiple episodes may occur within 1 admis-
sion. We identiﬁ  ed all episodes of pneumonia from April 
1997 through March 2005 by searching the HES database 
for ICD-10 codes J12–J18 in any of the 14 diagnostic 
ﬁ  elds. Episodes were classiﬁ  ed into those with pneumonia 
as a primary diagnosis and those with pneumonia listed in 
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any diagnostic ﬁ  eld. A patient identiﬁ  er—based on date of 
birth, postal code, and sex—was created for each episode 
and encrypted to ensure anonymity. This patient identiﬁ  er 
was then used to identify and order the number of episodes 
for each patient within 1 HES year, which runs from April 
through March. For our analyses, we retained only the ﬁ  rst 
episode for each patient because the main purpose of this 
analysis was to identify the number of persons admitted 
with pneumonia at least once a year, rather than to iden-
tify multiple episodes or admissions for the same patient. 
Because deaths may occur in episodes subsequent to the 
ﬁ  rst, we identiﬁ  ed patients who died in hospital with an 
ICD-10 code for pneumonia in any diagnostic ﬁ  eld within 
30 days of the ﬁ  rst admission with pneumonia. (Note that 
in-hospital deaths that were not associated with pneumo-
nia and deaths that occurred outside of hospital were not 
identiﬁ  ed.)
To adjust for coexisting conditions, we computed the 
Charlson Comorbidity Index score for each patient and 
grouped this into 4 levels: no coexisting conditions and 
mild, moderate, and severe coexisting conditions (11,12). 
This index includes 19 major disease categories and has 
been adapted and validated for use with hospital discharge 
data in ICD databases (13). Excess alcohol consumption 
is also a risk factor for pneumonia, but the Charlson index 
does not speciﬁ  cally include codes for alcohol use or alco-
hol-related illness. To address this, we also searched for 
the presence of >1 of the following alcohol-related ICD-
10 codes within each episode: F10*, G31.2, G62.1, I42.6, 
K29.2, K70*, K860, T51*, X45*, X65*, Y15*, Y919, 
Z721 (* indicates that either a 3-digit code is valid or that 
all 4th digits are valid).
Length of stay is recorded in HES and is equal to the 
difference between admission date and discharge date 
(where both are recorded). Differences between the median 
length of stay by year and age group were assessed by us-
ing a nonparametric equality-of-medians test.
Mid-year population estimates for England for 1997 
to 2004, stratiﬁ  ed by 5-year age groups and sex, were ob-
tained from the Ofﬁ  ce for National Statistics (ONS). The 
annual incidence rates of hospitalization for pneumonia 
were calculated overall and stratiﬁ  ed by age by using ONS 
population statistics as a denominator. Age-standardized 
incidence rates were calculated by using the 1997 English 
population as the reference standard. To identify seasonal 
patterns, the weekly number of admissions was summa-
rized, and a graph was created that showed the 4-week 
moving average number of pneumonia admissions (strati-
ﬁ  ed by patients <65 years and >65 years). We used mul-
tivariable logistic regression to examine changes in the 
odds of death (within 30 days after hospital admission for 
pneumonia) over time (years), controlling for known risk 
factors, e.g., age group, sex, and coexisting conditions. All 
analyses were performed by using Stata version 9.2 (Stata-
Corp LP, College Station, TX, USA).
Results
Incidence of Pneumonia (Primary Diagnosis)
The number of patients admitted to an NHS hospital in 
England at least once per year with a primary diagnosis of 
pneumonia increased from ≈72,060 in 1997–98 to 101,381 
in 2004–05. Overall, the age-standardized incidence rate rose 
by 34% over the study period from 1.48 per 1,000 population 
to 1.98 per 1,000 population (Table 1). This increase was 
noted in all age groups but was most marked in older adults. 
The age-speciﬁ  c incidence of hospitalization with pneumo-
nia as a primary diagnosis was 7% higher overall for male 
patients than for female patients over the study period. The 
percentage of total admissions that were due to pneumonia 
increased over the study period (online Appendix Figure 1, 
available from www.cdc.gov/EID/content/14/5/727-appG1.
htm). Figure 1 shows the trends in speciﬁ  c diagnoses of 
pneumonia. Most of the increase over the study period was 
observed after 2000–2001 in just 2 codes, J181 (lobar pneu-
monia, unspeciﬁ  ed) and J189 (pneumonia, unspeciﬁ  ed). Di-
agnoses of J180 (bronchopneumonia, unspeciﬁ  ed) decreased 
over the study period. Only 6% of episodes with pneumonia 
as a primary diagnosis had a causative pathogen within that 
primary diagnostic code. Of these, the most common organ-
isms speciﬁ  ed  were  S. pneumoniae (37%), Mycoplasma 
pneumoniae (26%), Streptococci other than group B and S. 
pneumoniae (10%), Staphylococcus spp. (8%), and Haemo-
philus inﬂ  uenzae (8%).
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Table 1. Age-standardized incidence of hospital admission for pneumonia (primary diagnosis) by age group per 1,000 population, England* 
HES year (April through March)  All ages  <65 y  65–74 y  75–84 y  >85 y 
1997–98 1.48 0.70 2.63 6.84 15.99
1998–99 1.67 0.72 3.02 8.08 18.59
1999–2000 1.62 0.65 3.04 8.05 18.80
2000–01 1.50 0.65 2.67 7.08 16.75
2001–02 1.67 0.71 3.02 7.73 18.89
2002–03 1.77 0.75 3.20 8.14 19.62
2003–04 1.91 0.78 3.46 8.79 22.41
2004–05 1.98 0.84 3.55 8.77 22.18
% change from 1997–98 to 2004–05  34 20 35 28 39
*HES, Hospital Episode Statistics. Increasing Hospital Admissions for Pneumonia, England
Pneumonia in Any Diagnosis
The number of hospitalizations for which pneumonia 
was listed in any diagnostic ﬁ  eld increased from 110,143 
to 153,312; the equivalent age-standardized rate increased 
32%, from 2.26 per 1,000 to 2.98 per 1,000 population over 
the same period. The trends in the rate of hospitalization 
with at least 1 pneumonia episode per year were very simi-
lar when we compared pneumonia as a primary diagnosis 
with any listed diagnosis (data not shown).
Coexisting Conditions
The proportion of patients with a primary diagnosis of 
pneumonia and coexisting conditions (deﬁ  ned by Charl-
son Comorbidity Index score) varied over time and by age 
(Figure 2). In all age groups, the proportion of patients 
with coexisting conditions increased between 1997–98 
and 2004–05. The median number of ICD-10 diagnoses 
recorded increased from 2 in 1997–98 to 3 in 2004–05 in 
patients with a primary diagnosis of pneumonia, and from 
3 to 4 in those with pneumonia in any diagnostic ﬁ  eld. In 
each year, <1% of patients overall (range 0.5%–1%) had 
an additional alcohol-related code recorded. These codes 
were slightly more common (range 0.9%–1.9%) in those 
<65 years of age compared to those >65 years of age (range 
0.3%–0.5%).
Length of Stay
Length of stay was recorded in HES for 73% of ad-
missions. Where reported, the median duration of stay (all 
ages) for those with a primary diagnosis of pneumonia was 
5 days for all years apart from 1999–2000 (6 days, p<0.001 
compared to 1997–98) and 2004–05 (4 days, p<0.001 com-
pared to 1997–98). For all-cause admissions, the median 
length of stay was 2 days each year in the study period. 
The median duration of stay in hospital increased with age. 
For those with a primary diagnosis of pneumonia, length 
of stay was 3 days for patients <65 years of age, 6 days for 
those 65–74 years, 8 days for those 75–84 years, and 9 days 
for those >85 years (p<0.001).
Admission Patterns
To assess any possible changes in admission practices 
and patterns, we analyzed the proportion of weekend ad-
missions compared to those at midweek. Overall, the pro-
portion of admissions with a primary diagnosis of pneumo-
nia that occurred on a Saturday or Sunday only changed 
from 23% to 24% between 1997–98 and 2004–05. In adults 
>85 years of age, the increase in weekend admissions was 
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Figure  1. Trends in age-standardized incidence of hospital 
admission with a primary diagnosis of pneumonia-speciﬁ  c 
International Classiﬁ  cation of Diseases (10th revision) codes, by 
Hospital Episode Statistics year (April to March). *Additional data 
on percentage of all admissions due to pneumonia published by 
the Information Centre for Health and Social Care (www.ic.nhs.uk). 
Data not available for 1997–98.
Figure 2. Percentage of patients 
admitted to hospital with a 
primary diagnosis of pneumonia 
with coexisting conditions, as 
deﬁ   ned by using the Charlson 
Comorbidity Index, by age 
group.RESEARCH
slightly greater, increasing from 22.5% in 1997–98 to 
25.2% in 2004–05 (p<0.001).
A clear seasonal variation in admissions for pneumonia 
occurred; incidence was highest in the winter months. Sea-
sonal patterns were similar for those <65 of age and those 
>65 years of age (online Appendix Figure 2, available from 
www.cdc.gov/EID/content/14/5/727-appG2.htm).
Mortality Rates 
The crude 30-day in-hospital mortality rates for all 
ages were fairly stable over the study period, declining 
slightly in older adults (Figure 3). Mortality rates were 
higher in the older age groups; in adults >85 years of age; 
47% were reported to have died in the hospital within 30 
days of admission with a primary diagnosis of pneumonia 
over the study period.
After age, sex, and Charlson Comorbidity Index score 
were controlled for, the odds of death within 30 days were 
signiﬁ  cantly higher in 1998–99 and 1999–2000 compared 
to 1997–98, and signiﬁ  cantly lower from 2000–01 onwards 
(Table 2). The odds of death were lowest in 2004–05, al-
though this ﬁ  nding may partly reﬂ  ect censoring of the data 
at the end of the study period. The odds of death rose with 
severity of the Charlson Comorbidity Index score and with 
increasing age (Table 2).
Discussion
The age-standardized incidence of hospital admis-
sions for pneumonia in England increased 34% between 
1997–98 and 2004–05. The increase occurred particularly 
in nonspeciﬁ  c codes—lobar pneumonia, unspeciﬁ  ed; and 
pneumonia, unspeciﬁ   ed—and was more marked among 
older age groups. The proportion of patients with recorded 
coexisting conditions increased over the study period; al-
cohol-related codes were recorded infrequently. In-hospital 
deaths among patients admitted with pneumonia were high, 
particularly in the most elderly and those with severe coex-
isting conditions. After adjustment, the odds of death were 
lower in more recent years compared to 1997–98.
The magnitude of the increase in hospital admission 
is similar to that reported in the United States (1) and Den-
mark (3). Our ﬁ  ndings also correspond with the reported 
rise in the extent of pneumonia in adult intensive care units 
in the United Kingdom, where community-acquired pneu-
monia admissions rose by 128% between 1996 and 2004, 
compared to a rise in total admissions of 24% (14). In con-
trast to hospital admissions, reports from primary care show 
that consultations for respiratory tract infections as a whole 
have markedly decreased (15,16) and that the overall mean 
weekly incidence of “pneumonia and pneumonitis” de-
creased from 3.69 per 100,000 in 1997 to 1.39 per 100,000 
in 2005 (data from the Birmingham Research Unit of the 
Royal College of General Practitioners, www.rcgp.org.uk/
bru_/bru_home.aspx). In adults >75 years of age, the mean 
weekly incidence declined from 16.9 and 14.6 per 100,000 
(in men and women, respectively) in 1999 to 6.5 and 5.5 
per 100,000 in 2005.
Whether the decline in the case-fatality rate over the 
study period is due to improved care leading to better out-
comes, or to patients with less severe pneumonia being ad-
mitted, is not clear. The number of ONS-registered deaths 
with pneumonia as an underlying cause in England has 
fallen since 2001, but this is thought to be primarily due to 
changes in the rules for classifying deaths and the switch 
from ICD-9 to ICD-10 coding in 2001 (17). A reduction 
in the length of stay in hospital may also indicate that less 
severe case-patients are being admitted to hospital, but we 
found only slight variation in the median length of stay 
over time (i.e., 6 days vs. 4 days). 
The rise in pneumonia hospitalizations may be attribut-
able to population factors, changes in HES coding, changes 
to health service organization, other biologic phenomenon, 
or a combination of these effects. We assessed some of 
these factors with our database, and we discuss possible 
explanations for the observed trends in pneumonia below.
Age, coexisting conditions, and residence in nursing 
homes are among the established risk factors for commu-
nity-acquired pneumonia (18). The United Kingdom has 
an aging population; ONS population statistics for 1997 
through 2004 show a 13% increase in the number of adults 
in England >80 years of age and a 25% increase in those 
>90 years. To control for this fact, we present our results as 
age-standardized incidence, although we cannot take into 
account other secular trends, such as increasing numbers 
of elderly persons living alone with little support. The pro-
portion of patients with reported coexisting conditions in-
creased over the study period in all age groups. This may 
reﬂ  ect a true increase in the prevalence of heart disease, 
diabetes, and other conditions in the population (19), but 
it may also be a reﬂ  ection of improved coding in HES, as 
the median number of diagnoses per patient increased over 
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Figure 3. Percentage of patients admitted with a primary diagnosis 
of pneumonia who died in hospital with pneumonia within 30 days 
of their ﬁ  rst pneumonia admission, by Hospital Episode Statistics 
year (April to March). Increasing Hospital Admissions for Pneumonia, England
the study period. Because the residential status of patients 
is not recorded in HES, we could not analyze the impact of 
place of residence directly, but there has been little recent 
change in the numbers and proportions of elderly persons 
living in residential care (20).
HES is essentially an administrative database; never-
theless, it has been widely used for epidemiologic stud-
ies. Diagnoses are recorded by coding clerks who review 
patient case notes, rather than by the attending physician, 
and some variability in the quality and consistency of 
coding is likely. We attempted to control for this vari-
ability by principally reporting on case-patients with 
pneumonia as a primary diagnosis. We also demonstrated 
that the proportion of admissions attributed to pneumonia 
increased over the period. Nevertheless, we have not at-
tempted to verify the accuracy of the diagnoses recorded 
in HES. Since our analyses are based on the ﬁ  rst admis-
sion for pneumonia in a year, most cases are likely to be 
community-acquired, but we have not excluded some 
potential sources of hospital-acquired pneumonia, e.g., 
patients recently hospitalized for reasons other than pneu-
monia before their pneumonia episode.
Changes in healthcare organization in England may 
have contributed to some of the increase in admissions and 
may help to explain the contrasting trends in hospital ad-
mission and primary care consultations. General practitio-
ners are no longer obliged to provide after-hours care, so 
patients with pneumonia may go directly to hospital, or be 
seen by an unfamiliar doctor who may be more likely than 
the patient’s usual general practitioner to admit him or her 
to hospital. The proportion of admissions occurring on a 
weekend (a proxy for after-hours admissions because HES 
only contains information on the date of admission and not 
the time) changed little overall, and only increased slightly, 
from 22.5% to 25.2%, between 1997–98 and 2004–05 for 
adults >85 years. The high in-hospital death rate observed 
in this age group may also reﬂ  ect people’s unwillingness to 
have a patient die at home; data on place of death suggest 
that the percentage of deaths (from all causes) in England 
and Wales that occurs outside a hospital or other medical 
establishment fell slightly, from 30.6% in 1998 to 25.9% in 
2004 (21). The level of care available to elderly patients has 
also improved, as evidenced by the introduction of the Na-
tional Service Framework for older people in 2001 and an 
increasing number of specialists in geriatric medicine (22). 
Expectations of patients and families may also be changing. 
Organizational changes may be contributing to the observed 
trends; however, similar trends have been observed in other 
countries, so this is unlikely to be the sole explanation.
A range of organisms are implicated in the etiology 
of community-acquired pneumonia. These include S. pneu-
moniae, M. pneumoniae, H. inﬂ  uenzae, Chlamydia species, 
Legionella species, Staphylococcus aureus, and respiratory 
viruses (inﬂ  uenza, respiratory syncytial virus [RSV], ad-
enovirus, parainﬂ  uenza) (6,23,24). In this study, only 6% 
of hospital admissions had a speciﬁ  c pathogen identiﬁ  ed in 
the primary diagnostic code. The absence of microbiologic 
data in these cases means that indirect methods must be 
used to investigate the underlying etiology. For example, 
Muller-Pebody et al. (25) used seasonal regression models 
to estimate that 42% of hospital admissions for unspeci-
ﬁ  ed pneumonia were attributable to S. pneumoniae, 10% to 
inﬂ  uenza, 9% to H. inﬂ  uenzae, 7% to Bordetella pertussis, 
and 5% to RSV. Further analysis is required to investigate 
whether such model estimates are similar when more re-
cent HES data are used.
Another factor to consider is that community prescrib-
ing of antimicrobial agents has decreased substantially in 
the United Kingdom in recent years (26). Reduced usage 
of antimicrobial agents in general practice may be related 
to increased pneumonia deaths (27). The cause of this re-
duction in usage of antimicrobial agents, either as a result 
of higher prescribing thresholds or fewer consultations 
for respiratory illness, has been debated (16,27–29). In ei-
ther case, a plausible argument can be made that reduced 
use of these agents may result in increased or prolonged 
(asymptomatic) carriage and thus transmission of common 
respiratory pathogens that cause pneumonia in the popu-
lation. This ecologic effect is difﬁ  cult to substantiate, and 
reductions in antimicrobial agents seem to predate the rise 
in pneumonia hospitalizations. Nonetheless, international 
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Table 2. Odds of death within 30 days of admission for 
hospitalized patients with a primary diagnosis of pneumonia* 
Variable No. deaths (%) 
Adjusted odds ratio† 
(95% CI) 
Year (April to March) 
 1997–98  17,743  (24.8)  1.00
  1998–99  22,152 (27.2)  1.07 (1.05–1.10) 
  1999–2000  22,425 (28.2)  1.07 (1.04–1.10) 
  2000–01  19,392 (26.1)  0.94 (0.92–0.97) 
  2001–02  22,198 (26.5)  0.93 (0.90–0.95) 
  2002–03  23,352 (26.2)  0.89 (0.87–0.91) 
  2003–04  25,946 (26.7)  0.88 (0.86–0.90) 
  2004–05  25,379 (25.0)  0.80 (0.78–0.82) 
Age, y 
 <65  13,576  (5.6)  1.00
  65–74  25,349 (25.1)  4.34 (4.25–4.44) 
  75–84  67,526 (37.0)  7.77 (7.61–7.93) 
! 85 72,136 (47.2)  12.81 (12.55–13.08) 
Sex 
 M  87,132  (25.2)  1.00
  F  91,455 (27.6)  0.97 (0.96–0.98) 
Comorbidity index 
 None  63,254  (16.9)  1.00
  Mild  54,030 (31.9)  1.59 (1.56–1.61) 
  Moderate  33,598 (42.9)  2.47 (2.42–2.51) 
  Severe  27,705 (50.1)  3.72 (3.65–3.80) 
*Results from a multivariable logistic regression. CI, confidence interval. 
†Model includes year, age, sex, and coexisting conditions. RESEARCH
comparisons of pneumonia hospitalizations and drug-pre-
scribing trends may be enlightening.
The increase in pneumonia admissions has occurred 
despite increasing coverage for inﬂ  uenza and pneumococ-
cal vaccinations in the elderly (30,31). Since 1992, a 23-
valent pneumococcal polysaccharide vaccine (PPV23) has 
been recommended in England for persons at high risk, 
and in 2003, this recommendation was extended to include 
all persons >65 years of age. This universal program was 
phased in over 3 years, targeting those >80 years of age 
from August 2003, >75 years of age from April 2004, and 
>65 years of age from April 2005. Although PPV23 of-
fers a modest level of protection against invasive disease, 
the vaccine appears to have little beneﬁ  t against pneumo-
nia (7). A person’s vaccination status is not recorded in 
HES so we could only explore the association between 
PPV23 and pneumonia at an ecologic level. We did not 
observe any associations between the trends of PPV23 
coverage and overall pneumonia incidence (ICD-10 
codes J12–J18). PPV23 coverage increased steadily from 
1995 onwards (30); from 2003 onwards, coverage in-
creased in the age groups targeted in the universal pro-
gram. By contrast, the incidence of pneumonia increased 
in all age groups from 2001–02 onwards. The trend in 
pneumococcal pneumonia (ICD10 code J13X), which is 
most likely to represent conﬁ  rmed pneumococcal pneu-
monia, was stable, suggesting that PPV23 had little in-
ﬂ  uence. The experience of the United States leads us to 
expect that the introduction of the 7-valent pneumococ-
cal conjugate vaccine (PCV7) into the United Kingdom 
infant immunization schedule in September 2006 will re-
sult in a reduction in the transmission of pneumococcal 
vaccine serotypes and subsequent reductions in invasive 
(32–34), and to a lesser extent noninvasive, pneumococcal 
disease (including pneumonia) (10) even in unvaccinated 
persons. Analysis of temporal trends in Pneumococcus-
attributable illnesses pre- and post-PCV7 introduction 
will help to quantify these effects in England.
Conclusion
We have observed a 34% increase in the incidence of 
hospital admissions for pneumonia in England in recent 
years, particularly in older adults. We believe this increase 
is real; however, the trends are not fully explained by an ag-
ing population, rising prevalence of coexisting conditions, or 
coding changes. Further research is required to understand 
the reasons for the increase in pneumonia hospitalizations so 
that the most appropriate interventions can be determined.
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